Drugs / VPM1002(Hyg+)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02391415 | Jun 2015 → Nov 2017 | tuberculosis | Serum Institute of India Pvt. Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VPM1002(Hyg+) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02391415 ↗ |